We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Hospital Infections Program, National Center for Infectious Diseases, Mailstop E-55, 1600 Clifton Rd NE, Centers for Disease Control and Prevention, Atlanta, GA 30333
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Cetron, MS, Jernigan, DB, Breiman, RF. Action plan for drug-resistant Streptococcus pneumoniae. Emerging Infectious Diseases1995;1:64–65.CrossRefGoogle ScholarPubMed
2
2.Centers for Disease Control and Prevention: Drug-resistant Streptococcus pneumoniae—Kentucky and Tennessee, 1993. MMWR1994;43:23–25.Google Scholar
3
3.Hofman, J, Cetron, MS, Farley, MM, et al.The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med1995;333:481–486.CrossRefGoogle Scholar
4
4.Gorwitz, RJ, Nakashima, AK, Moran, JS, Knapp, JS. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae—United States, 1988-1991. MMWR1993;42(SS-3):29–39.Google ScholarPubMed
5
5.Emori, TG, Gaynes, RP. An overview of nosocomial infections including the role for the microbiology laboratory. Clin Microbiol Rev1993;6:428–442.CrossRefGoogle ScholarPubMed
6
6.Lee, LA, Puhr, ND, Maloney, EK, et al.Increase in antimicrobial resistant-Salmonella infections in the United States, 1989-1990. J Infect Dis1994;170:128–134.CrossRefGoogle ScholarPubMed
7
7.Ries, AR, Wells, JG, Olibola, A. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention. J Infect Dis1994;169:1035–1041.Google Scholar
9.Lorian, V. The need for sur veillance for antimicrobial resistance. Infect Control Hosp Epidemiol1995;16:638–641.CrossRefGoogle Scholar
10
10.Atkinson, BA, Lorian, V. Antimicrobial agent susceptibility patterns in bacteria in hospitals from 1971-1982. J Clin Microbiol1984;20:791–796.CrossRefGoogle Scholar
11
11.Centers for Disease Control. Guidelines for evaluating surveillance systems. MMWR1988;37(S-5):1–17.Google Scholar
12
12.Gaynes, R, Culver, D, the National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol1991;13:10–14.Google Scholar
13
13.Panlilio, A, Culver, DH, Gaynes, RP, et al.Methicillin-resistant Staphylococcus aureus in the United States, 1975-1991. Infect Control Hosp Epidemiol1992;13:582–586.Google ScholarPubMed
14
14.Gaynes, RP, Culver, DH, the National Nosocomial Infections Surveillance System. Temporal trends in methicillin-resistant Staphylococcus aureus in the United States. Infect Dis Clin Practice1993;2:452–455.Google Scholar
15
15.Burwen, DR, Banerjee, SN, Gaynes, RP, the National Nosocomial Infections Sur veillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis1994;170:1622–5.CrossRefGoogle ScholarPubMed
16
16.Coronado, V, Gaynes, R, Edwards, J, the National Nosocomial Infections Sur veillance System. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol1995;16:71–75.CrossRefGoogle ScholarPubMed
17
17.Monnet, D, Edwards, J, Gaynes, R. Extended spectrum β-lactam-resistant Klebsiella pneumoniae: epidemiologic evidence of interhospital transmission. Infect Control Hosp Epidemiol1994;15:23. Abstract #24.Google Scholar
18
18.Langmuir, AD. The surveillance of communicable diseases of national importance. N Engl J Med1963;268:182–192.CrossRefGoogle ScholarPubMed